Education
About Us
Working with TipRanks
Follow Us
RELIEF THERAPEUTICS Holding (CH:RLF)
:RLF
RLF Stock Chart & Stats
CHF1.90
-CHF0.17(-5.52%)
At close: 4:00 PM EST
CHF1.90
-CHF0.17(-5.52%)
Day’s Range― - ―
52-Week RangeCHF1.65 - CHF4.80
Previous CloseN/A
Volume10.22K
Average Volume (3M)36.57K
Market Cap
CHF416.60M
Enterprise ValueCHF16.26M
Total Cash (Recent Filing)CHF12.50M
Total Debt (Recent Filing)CHF1.90M
Price to Earnings (P/E)―
Beta-0.92
Next Earnings
Apr 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding154,102,450
10 Day Avg. Volume19,929
30 Day Avg. Volume36,567
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.44
Price to Sales (P/S)6.27
P/FCF Ratio-17.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RELIEF THERAPEUTICS Holding News
RLF FAQ
What was RELIEF THERAPEUTICS Holding’s price range in the past 12 months?
RELIEF THERAPEUTICS Holding lowest stock price was CHF1.65 and its highest was CHF4.80 in the past 12 months.
What is RELIEF THERAPEUTICS Holding’s market cap?
RELIEF THERAPEUTICS Holding’s market cap is CHF416.60M.
When is RELIEF THERAPEUTICS Holding’s upcoming earnings report date?
RELIEF THERAPEUTICS Holding’s upcoming earnings report date is Apr 09, 2026 which is in 105 days.
How were RELIEF THERAPEUTICS Holding’s earnings last quarter?
RELIEF THERAPEUTICS Holding released its earnings results on Aug 29, 2025. The company reported -CHF0.357 earnings per share for the quarter, missing the consensus estimate of N/A by -CHF0.357.
Is RELIEF THERAPEUTICS Holding overvalued?
According to Wall Street analysts RELIEF THERAPEUTICS Holding’s price is currently Overvalued.
Does RELIEF THERAPEUTICS Holding pay dividends?
RELIEF THERAPEUTICS Holding does not currently pay dividends.
What is RELIEF THERAPEUTICS Holding’s EPS estimate?
RELIEF THERAPEUTICS Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RELIEF THERAPEUTICS Holding have?
RELIEF THERAPEUTICS Holding has 154,102,450 shares outstanding.
What happened to RELIEF THERAPEUTICS Holding’s price movement after its last earnings report?
RELIEF THERAPEUTICS Holding reported an EPS of -CHF0.357 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.23%.
Which hedge fund is a major shareholder of RELIEF THERAPEUTICS Holding?
Currently, no hedge funds are holding shares in CH:RLF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
RELIEF THERAPEUTICS Holding
RELIEF THERAPEUTICS Holding (RLF) is a biotechnology company focused on the development and commercialization of innovative therapies for patients suffering from various unmet medical needs. The company operates primarily in the biotechnology sector, with a strong emphasis on developing treatments for conditions such as respiratory diseases, neurological disorders, and metabolic disorders. RLF's core products include innovative drug candidates that target specific pathways associated with these diseases, aiming to improve patient outcomes and quality of life.
Technical Analysis
Molecular Partners AG
―
Basilea Pharmaceutica
―
Idorsia Ltd
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―
Options Prices
Currently, No data available
---